Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[Amatuer17]

I liked the company based on clean b/s, good operations and end of successful P3 trial and near NDA.

After Pfizer trial results comparing NSAID with Celebrex - KTOV shine has gone.

The new acquisition is a very long term strategy - as products are in pre-clinical stage. cancer trials are high risk, long duration, high cost with high probability of failure.

My expectation of this being multi bagger have gone down very much. Already making loss based on my entry point. Now hope to recover my investment and probably some modest profit after NDA filing when it happens. Not sure if BO is in the making.